Regulation and therapy: the role of ferroptosis in DLBCL
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of B-cell non-Hodgkin’s lymphoma (NHL), up to 30%–40% of patients will relapse and 10%–15% of patients have primary refractory disease, so exploring new treatment options is necessary. Ferroptosis is a non-apoptotic cell death mode dis...
Saved in:
Main Authors: | Yifan Wang, Zhengmei He, Xinyu Dong, Yiming Yao, Qiuni Chen, Yuye Shi, Yuan Deng, Quane Zhang, Liang Yu, Chunling Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1458412/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The prognostic value of the platelet-to-lymphocyte ratio in multiple myeloma patients treated with a bortezomib-based regimen
by: Quane Zhang, et al.
Published: (2025-01-01) -
Prognostic significance of CDK1 expression in diffuse large B-Cell lymphoma
by: Qiuni Chen, et al.
Published: (2025-01-01) -
Le risque cyclonique dans l’Atlantique en 2008
by: Sandra Rome
Published: (2008-10-01) -
Training for Sustainable and Healthy Building for 2050: New Methodologies for an Integrated and Transnational Education Approach Targeting Skills Development for the Transition Toward ZEB and PEB Buildings
by: Maria K. Koukou, et al.
Published: (2024-12-01) -
IKEChecker: grammar-guided stateful fuzzer for IKE protocol implementions
by: ZHENG Yonghui, et al.
Published: (2024-08-01)